Role of perivascular nerve and sensory neurotransmitter dysfunction in inflammatory bowel disease

Am J Physiol Heart Circ Physiol. 2021 May 1;320(5):H1887-H1902. doi: 10.1152/ajpheart.00037.2021. Epub 2021 Mar 12.

Abstract

Inflammatory bowel disease (IBD) is associated with both impaired intestinal blood flow and increased risk of cardiovascular disease, but the functional role of perivascular nerves that control vasomotor function of mesenteric arteries (MAs) perfusing the intestine during IBD is unknown. Because perivascular sensory nerves and their transmitters calcitonin gene-related peptide (CGRP) and substance P (SP) are important mediators of both vasodilation and inflammatory responses, our objective was to identify IBD-related deficits in perivascular sensory nerve function and vascular neurotransmitter signaling. In MAs from an interleukin-10 knockout (IL-10-/-) mouse model, IBD significantly impairs electrical field stimulation (EFS)-mediated sensory vasodilation and inhibition of sympathetic vasoconstriction, despite decreased sympathetic nerve density and vasoconstriction. The MA content and EFS-mediated release of both CGRP and SP are decreased with IBD, but IBD has unique effects on each transmitter. CGRP nerve density, receptor expression, hyperpolarization, and vasodilation are preserved with IBD. In contrast, SP nerve density and receptor expression are increased, and SP hyperpolarization and vasodilation are impaired with IBD. A key finding is that blockade of SP receptors restores EFS-mediated sensory vasodilation and enhanced CGRP-mediated vasodilation in MAs from IBD but not Control mice. Together, these data suggest that an aberrant role for the perivascular sensory neurotransmitter SP and its downstream signaling in MAs underlies vascular dysfunction with IBD. We propose that with IBD, SP signaling impedes CGRP-mediated sensory vasodilation, contributing to impaired blood flow. Thus, substance P and NK1 receptors may represent an important target for treating vascular dysfunction in IBD.NEW & NOTEWORTHY Our study is the first to show that IBD causes profound impairment of sensory vasodilation and inhibition of sympathetic vasoconstriction in mesenteric arteries. This occurs alongside decreased SP-containing nerve density and increased expression of NK1 receptors for SP. In contrast, CGRP dilation, nerve density, and receptor expression are unchanged. Blocking NK1 receptors restores sensory vasodilation in MAs and increases CGRP-mediated vasodilation, indicating that SP interference with CGRP signaling may underlie impaired sensory vasodilation with IBD.

Keywords: adventitia; calcitonin gene-related peptide; inflammation; substance P; sympathetic nerves; vasodilation.

Publication types

  • Research Support, N.I.H., Extramural
  • Webcast

MeSH terms

  • Animals
  • Calcitonin Gene-Related Peptide / metabolism*
  • Disease Models, Animal
  • Female
  • Helicobacter hepaticus
  • Inflammatory Bowel Diseases / genetics
  • Inflammatory Bowel Diseases / metabolism*
  • Inflammatory Bowel Diseases / microbiology
  • Inflammatory Bowel Diseases / physiopathology
  • Interleukin-10 / deficiency
  • Interleukin-10 / genetics
  • Male
  • Mesenteric Arteries / innervation*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptors, Calcitonin Gene-Related Peptide / metabolism
  • Receptors, Neurokinin-1 / metabolism
  • Sensory Receptor Cells / metabolism*
  • Signal Transduction
  • Splanchnic Circulation*
  • Substance P / metabolism*
  • Sympathetic Nervous System / physiopathology*
  • Vasoconstriction
  • Vasodilation

Substances

  • IL10 protein, mouse
  • Receptors, Calcitonin Gene-Related Peptide
  • Receptors, Neurokinin-1
  • Interleukin-10
  • Substance P
  • Calcitonin Gene-Related Peptide